CClinicalTrials.gg
Enrolling by invitationNCT07215039Updated Apr 17, 2026

Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida

An observational study in Hematopoietic and Lymphatic System Neoplasm and Malignant Solid Neoplasm, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-17.

Sponsored by Mayo Clinic · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1,200
Ages
18 Years and older
Sex
Female
01

Study summary

This study evaluates cancer screening awareness, personal and family cancer history, and barriers to screening among incarcerated women at Gadsden Correctional Facility. The information will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines that will be disseminated to US prisons and incorporated into release programs and general health literacy programs.

02

Conditions studied

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women currently incarcerated at Gadsden Correctional Facility

Inclusion criteria

  • Women aged 18+ currently incarcerated at Gadsden Correctional Facility
  • Pregnant participants are allowed

Exclusion criteria

Exclusion Criteria:

  • Women under 18 or not incarcerated
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1,200 participants (estimated)

Groups and cohorts

  • Observational

    Participants complete a survey on study.

    Other: Survey

Interventions

  • OtherSurvey

    Non-interventional study

06

What researchers measure

Primary outcomes

  1. Self-reported cancer screening history

    Assessed as the proportion of incarcerated women who meet national cancer screening guidelines based on self-reported screening history. Participants will complete a 4-page, paper-based, anonymous survey that should take approximately 15 minutes to complete. The survey consists of mainly yes/no questions with a few multiple choice and open-ended questions. This is a qualitative survey used to record basic demographic information, cancer knowledge, risk factors, screening history, and adherence to preventive cancer care. Survey results will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines.

    Time frame: Baseline (completion of survey)

Secondary outcomes

  1. Awareness of cancer risk factors

    Participants will complete a 4-page, paper-based, anonymous survey that should take approximately 15 minutes to complete. The survey consists of mainly yes/no questions with a few multiple choice and open-ended questions. This is a qualitative survey used to record basic demographic information, cancer knowledge, risk factors, screening history, and adherence to preventive cancer care. Survey results will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines.

    Time frame: Baseline (completion of survey)

  2. Awareness of cancer screening guidelines

    Participants will complete a 4-page, paper-based, anonymous survey that should take approximately 15 minutes to complete. The survey consists of mainly yes/no questions with a few multiple choice and open-ended questions. This is a qualitative survey used to record basic demographic information, cancer knowledge, risk factors, screening history, and adherence to preventive cancer care. Survey results will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines.

    Time frame: Baseline (completion of survey)

  3. Barriers to cancer screening within correctional settings

    Participants will complete a 4-page, paper-based, anonymous survey that should take approximately 15 minutes to complete. The survey consists of mainly yes/no questions with a few multiple choice and open-ended questions. This is a qualitative survey used to record basic demographic information, cancer knowledge, risk factors, screening history, and adherence to preventive cancer care. Survey results will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines.

    Time frame: Baseline (completion of survey)

  4. Barriers to cancer screening follow-up within correctional settings

    Participants will complete a 4-page, paper-based, anonymous survey that should take approximately 15 minutes to complete. The survey consists of mainly yes/no questions with a few multiple choice and open-ended questions. This is a qualitative survey used to record basic demographic information, cancer knowledge, risk factors, screening history, and adherence to preventive cancer care. Survey results will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines.

    Time frame: Baseline (completion of survey)

07

Study locations

1 site
  • Mayo Clinic in Florida
    Jacksonville, Florida 32224-9980, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07215039
Lead sponsor
Mayo Clinic
Responsible party
Sponsor
First posted
Oct 10, 2025
Start date
Nov 10, 2025
Primary completion
Oct 30, 2027 (estimated)
Completion
Oct 30, 2027 (estimated)
Last update
Apr 17, 2026

Study contacts

Oluwadamilola T. Oladeru, MD, MBA
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion